← All stocks

Passage BIO, Inc.

PASG Net buying
CIK 0001787297 #5149 in the set updated 18 Sep 2026
Bought (120 mo)
$43.03M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.94M
$0.00 on a plan · $341.38K straight out of an exercise
Sold at will
$1.60M
36 of 43 sales
Net
+$41.09M
+$41.43M against sales at will

By person

22 insiders · 86 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ORBIMED ADVISORS LLC entity
10% owner
$12.48M (12)
$1.01M (25)
+$11.47M
20,047,666
$82.55M
+46.7%
Frazier Life Sciences IX, L.P.
10% owner
$9.90M (1)
+$9.90M
5,009,219
$20.63M
Heron Patrick J
Director
$9.90M (1)
+$9.90M
5,009,219
$20.63M
Versant Venture Capital VI, L.P. entity
10% owner
$4.05M (1)
+$4.05M
4,959,769
$20.42M
Woiwode Thomas
Director
$4.05M (1)
+$4.05M
4,959,769
$20.42M
Lynx1 Capital Management LP entity
10% owner
$1.69M (11)
+$1.69M
673,759
$2.77M
Quigley Jill M.
Chief Operating Officer
$45.00K (2)
$529.58K (2)
−$484.58K
369,754
$1.52M
+31.9%
Countouriotis Athena
Director
$309.95K (2)
+$309.95K
18,900
$77.82K
Romano Gary
Chief Medical Officer
$211.01K (2) scheduled
−$211.01K
0
$0.00
Yamada Tadataka
Director
$117.00K (1)
+$117.00K
656,149
$2.70M
+1.0%
Fotopoulos Alexandros
Chief Technical Officer
$99.00K (1)
$8.73K (2) scheduled
+$90.27K
28,693
$118.14K
+381.0%
Islam Saqib
Director
$90.00K (1)
+$90.00K
5,000
$20.59K
Kapadia Sandip
Director
$90.00K (1)
$5.96K (1)
+$84.04K
0
$0.00
Goldsmith Bruce A
CEO and President
$77.53K (3)
+$77.53K
15,983
$65.81K
+454.4%
Chou William
PRESIDENT AND CEO
$75.16K (1) scheduled
−$75.16K
6,524
$26.86K
+987.3%
Borthwick Kathleen
CFO
$50.85K (4) scheduled
−$50.85K
5,402
$22.24K
Ratcliffe Liam
Director
$50.40K (1)
+$50.40K
2,800
$11.53K
Morris Richard Steven
Chief Financial Officer
$37.20K (2)
+$37.20K
5,454
$22.46K
+89.2%
Cale Edgar B.
GC & CORPORATE SECRETARY
$36.00K (1)
$14.39K (1)
+$21.61K
45,995
$189.38K
+369.0%
Forman Mark S
CHIEF MEDICAL OFFICER
$15.98K (2)
−$15.98K
48,631
$200.24K
+338.8%
King Simona
Chief Financial Officer
$12.23K (2) scheduled
−$12.23K
23,994
$98.80K
Toernsen Monika Maria
Chief Commercial Officer
$2.54K (1)
−$2.54K
3,319
$13.67K

No percentages here. This company's share count has moved by a factor of 19.6 over the window, from 3,178,710 to 62,148,274 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
ORBIMED ADVISORS LLC
26 Jun 2025
10% owner
Sell indirect
213,257
$0.33
$70.37K
ORBIMED ADVISORS LLC
25 Jun 2025
10% owner
Sell indirect
138,800
$0.33
$45.80K
ORBIMED ADVISORS LLC
24 Jun 2025
10% owner
Sell indirect
231,600
$0.35
$81.06K
ORBIMED ADVISORS LLC
24 Apr 2025
10% owner
Sell indirect
68,195
$0.32
$21.82K
ORBIMED ADVISORS LLC
23 Apr 2025
10% owner
Sell indirect
89,328
$0.34
$30.37K
ORBIMED ADVISORS LLC
22 Apr 2025
10% owner
Sell indirect
78,049
$0.34
$26.54K
ORBIMED ADVISORS LLC
17 Apr 2025
10% owner
Sell indirect
77,090
$0.33
$25.44K
ORBIMED ADVISORS LLC
16 Apr 2025
10% owner
Sell indirect
61,638
$0.33
$20.34K
ORBIMED ADVISORS LLC
15 Apr 2025
10% owner
Sell indirect
10,326
$0.38
$3.92K
Borthwick Kathleen
11 Feb 2025
CFO
Sell
3,183
$0.53
$1.69K
ORBIMED ADVISORS LLC
14 Jan 2025
10% owner
Sell indirect
79,024
$0.60
$47.41K
ORBIMED ADVISORS LLC
13 Jan 2025
10% owner
Sell indirect
17,986
$0.64
$11.51K
ORBIMED ADVISORS LLC
10 Jan 2025
10% owner
Sell indirect
126,209
$0.66
$83.30K
ORBIMED ADVISORS LLC
8 Jan 2025
10% owner
Sell indirect
75,007
$0.68
$51.00K
ORBIMED ADVISORS LLC
7 Jan 2025
10% owner
Sell indirect
52,536
$0.71
$37.30K
ORBIMED ADVISORS LLC
6 Jan 2025
10% owner
Sell indirect
19,481
$0.77
$15.00K
ORBIMED ADVISORS LLC
20 Dec 2024
10% owner
Sell indirect
230,321
$0.60
$138.19K
ORBIMED ADVISORS LLC
11 Dec 2024
10% owner
Sell indirect
80
$0.80
$64.00
ORBIMED ADVISORS LLC
10 Dec 2024
10% owner
Sell indirect
8,015
$0.80
$6.41K
ORBIMED ADVISORS LLC
9 Dec 2024
10% owner
Sell indirect
54,181
$0.84
$45.51K
ORBIMED ADVISORS LLC
6 Dec 2024
10% owner
Sell indirect
20,903
$0.82
$17.14K
ORBIMED ADVISORS LLC
4 Dec 2024
10% owner
Sell indirect
76,200
$0.79
$60.20K
ORBIMED ADVISORS LLC
19 Sep 2024
10% owner
Sell indirect
39,300
$0.71
$27.90K
ORBIMED ADVISORS LLC
18 Sep 2024
10% owner
Sell indirect
25,631
$0.73
$18.71K
ORBIMED ADVISORS LLC
17 Sep 2024
10% owner
Sell indirect
111,400
$0.73
$81.32K
ORBIMED ADVISORS LLC
16 Sep 2024
10% owner
Sell indirect
63,100
$0.74
$46.69K
Forman Mark S
13 Feb 2024
CHIEF MEDICAL OFFICER
Sell
1,638
$0.97
$1.59K
Borthwick Kathleen
13 Feb 2024
SVP, INTERIM CFO
Sell
1,470
$0.97
$1.43K
Forman Mark S
2 Jan 2024
Chief Medical Officer
Sell
15,813
$0.91
$14.39K
Cale Edgar B.
2 Jan 2024
GC & Corporate Secretary
Sell
15,813
$0.91
$14.39K
Borthwick Kathleen
2 Jan 2024
SVP, Interim CFO
Sell
10,672
$0.91
$9.71K
Fotopoulos Alexandros
16 Jun 2023
Chief Technical Officer
Sell
4,052
$0.93
$3.78K
Kapadia Sandip
1 Dec 2022
Director
Sell
5,000
$1.19
$5.96K
Toernsen Monika Maria
19 Sep 2022
Chief Commercial Officer
Sell
1,681
$1.51
$2.54K
Quigley Jill M.
20 Jan 2021
Chief Operating Officer
Sell
1,300
$30.01
$39.01K
Quigley Jill M.
14 Jan 2021
Chief Operating Officer
Sell
16,298
$30.10
$490.57K

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 23
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 24,273,474
Sales filed before the plan box existed 4
History held since 2 Mar 2020